Cara Therapeutics, Inc. - COM (CARA)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM
Shares, excl. options Q1 2024: 1.66 M
Holdings value Q1 2024: $1.51 M
Value change Q1 2024: -$1.31 M
Grand Portfolio weight change Q1 2024: 0%
Number of holders: 11
Number of buys Q1 2024: 1
Number of sells Q1 2024: -26
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: 0%
CUSIP: 140755109

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	1.66 M	$1.51 M	-$1.31 M	0	0	$0.90	11
2023 Q4	23.6 M	$17.6 M	-$4.88 M	8.55 K	42.8 K	$0.74	105
2023 Q3	26.7 M	$44.8 M	-$6.02 M	26.9 K	107 K	$1.68	116
2023 Q2	29 M	$82 M	-$18.3 M	26 K	284 K	$2.83	128
2023 Q1	33.4 M	$164 M	-$5.48 M	117 K	549 K	$4.91	159
2022 Q4	33.5 M	$360 M	-$4.58 M	648 K	1.19 M	$10.74	158
2022 Q3	34.5 M	$323 M	-$1.75 M	761 K	1.11 M	$9.36	147
2022 Q2	34.5 M	$315 M	+$22.8 M	638 K	2.82 M	$9.13	162
2022 Q1	31.6 M	$385 M	+$17.3 M	1.06 M	2.95 M	$12.15	173
2021 Q4	30.2 M	$368 M	+$3.28 M	2.71 M	3.99 M	$12.18	172
2021 Q3	29.5 M	$455 M	+$2.08 M	5 M	7.4 M	$15.45	161
2021 Q2	31.1 M	$443 M	-$29 M	4.94 M	4.03 M	$14.27	165
2021 Q1	29.8 M	$647 M	+$3.37 M	10.2 M	47.8 M	$21.71	156
2020 Q4	29.8 M	$451 M	-$10.8 M	3.97 M	11.2 M	$15.13	140
2020 Q3	30.6 M	$389 M	+$8.06 M	3.08 M	4.99 M	$12.73	145
2020 Q2	29.8 M	$509 M	+$22.2 M	5.06 M	8.65 M	$17.10	133
2020 Q1	32.1 M	$423 M	+$8.58 M	3.01 M	5.25 M	$13.21	123
2019 Q4	31.2 M	$503 M	+$4.14 M	7.31 M	7.03 M	$16.11	139
2019 Q3	30.3 M	$554 M	+$80.4 M	7.96 M	7.2 M	$18.28	136
2019 Q2	26 M	$559 M	+$83.4 M	16 M	19.1 M	$21.50	121
2019 Q1	22.3 M	$437 M	-$20.9 M	14 M	15.1 M	$19.62	126
2018 Q4	24.1 M	$313 M	-$4.83 M	4.76 M	3.49 M	$13.00	126
2018 Q3	23.4 M	$561 M	+$111 M	8.7 M	18.2 M	$23.95	139
2018 Q2	18.6 M	$357 M	+$23.5 M	14.3 M	14.8 M	$19.15	120
2018 Q1	17.9 M	$222 M	+$8.82 M	7.02 M	3.47 M	$12.38	113
2017 Q4	13.7 M	$167 M	-$24.1 M	5.75 M	3.26 M	$12.24	118
2017 Q3	15.5 M	$213 M	-$11.2 M	10.2 M	3.82 M	$13.69	114
2017 Q2	19.4 M	$298 M	+$38.2 M	27.9 M	15.3 M	$15.39	129
2017 Q1	16.9 M	$308 M	+$96.7 M	14.2 M	9.85 M	$18.39	108
2016 Q4	13.7 M	$127 M	+$12.7 M	545 K	1.12 M	$9.29	95
2016 Q3	11.6 M	$96.9 M	+$6.09 M	215 K	536 K	$8.35	77
2016 Q2	11.9 M	$57.3 M	-$25.7 M	0	0	$4.81	62
2016 Q1	16.2 M	$101 M	-$43.5 M	70 K	77 K	$6.22	88
2015 Q4	19.6 M	$331 M	+$19.9 M	0	239 K	$16.86	90
2015 Q3	18.5 M	$264 M	+$91.7 M	159 K	417 K	$14.29	85
2015 Q2	11.8 M	$143 M	+$15 M		389 K	$12.15	72
2015 Q1	11.1 M	$112 M	+$7.84 M			$10.05	58
2014 Q4	10.4 M	$104 M	-$3.31 M			$9.97	55
2014 Q3	9.72 M	$81.5 M	+$5.57 M			$8.39	53
2014 Q2	8.77 M	$149 M	+$1.05 M			$17.02	45
2014 Q1	8.62 M	$160 M	+$160 M			$18.61	42